GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
about
GEIS-21: a multicentric phase II study of intensive chemotherapy including gemcitabine and docetaxel for the treatment of Ewing sarcoma of children and adults: a report from the Spanish sarcoma group (GEIS).
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
GEIS-21: a multicentric phase ...... Spanish sarcoma group (GEIS).
@en
type
label
GEIS-21: a multicentric phase ...... Spanish sarcoma group (GEIS).
@en
prefLabel
GEIS-21: a multicentric phase ...... Spanish sarcoma group (GEIS).
@en
P2093
P2860
P356
P1476
GEIS-21: a multicentric phase ...... Spanish sarcoma group (GEIS).
@en
P2093
A Castañeda
A Lopez-Pousa
C Valverde
C de Torres
E Maradiegue
J Martinez-Trufero
P2860
P2888
P304
P356
10.1038/BJC.2017.252
P407
P577
2017-08-08T00:00:00Z
P6179
1091084231